The purpose of the proposed study is to delineate the basic immunological defects responsible for B cell hyperactivity in MRL/1 autoimmune mice. Three specific issues will be addressed: (1) In order to identify the intrinsic immune defect(s) resulting in excessive B cell activity, """"""""autoimmune x normal"""""""" chmieric mice will be produced in which T cells and B cells derived from a mixture of normal and auto-immune stem cells mature together in an autoimmune environment. The strains selected for the study differ with respect to their Thy-1 and Igh allotype markers such that it will be possible to monitor the extent and source (normal or autoimmune parent) of B cell antibody production as well as T cell lymphokine production; (2) To clarify the relationship between non-self antigen induced responses and autoantibody production, autoimmune mice capable of making a hapten specific cross-reactive idiotype (CRI) will be immunized with hapten-protein conjugates and screened periodically for expression of the CRI-associated VHDHJH in the polyclonally activated B cell pool; (3) To examine the role of autologous antigen in inducing an autoimmune response, backcross mice derived from mating autoimmune with normal mice will be produced and allotype specificity of rheumatoid factors derived from the Igh homozygous mice will be compared to the allotype specificity of rheumatoid factors derived from the Igh heterozygous mice. The autoimmune Igh heterozygous mice will also be used to look for possible linkage between anti-IgG binding specificities and the igh haplotype of the autoimmune parent. Overall these studies should contribute to our basic understanding of the mechanisms regulating B cell activation and antibody production. The results of this proposal should eventually have clinical application with regard to the control of the basic immunoregulatory defects involved in autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis as well as certain forms of graft-versus-host disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR035230-02
Application #
3157120
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1986-09-22
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Baum, Rebecca; Nündel, Kerstin; Pawaria, Sudesh et al. (2016) Synergy between Hematopoietic and Radioresistant Stromal Cells Is Required for Autoimmune Manifestations of DNase II-/-IFNaR-/- Mice. J Immunol 196:1348-54
Nündel, Kerstin; Green, Nathaniel M; Shaffer, Arthur L et al. (2015) Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses. J Immunol 194:2504-12
Bossaller, Lukas; Rathinam, Vijay A K; Bonegio, Ramon et al. (2013) Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus. J Immunol 191:2104-14
Uccellini, Melissa B; Busto, Patricia; Debatis, Michelle et al. (2012) Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence. Immunol Lett 143:85-91
Green, Nathaniel M; Moody, Krishna-Sulayman; Debatis, Michelle et al. (2012) Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. J Biol Chem 287:39789-99
Kiefer, Kerstin; Oropallo, Michael A; Cancro, Michael P et al. (2012) Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol 90:498-504
Green, Nathaniel M; Marshak-Rothstein, Ann (2011) Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23:106-12
Avalos, Ana Maria; Busconi, Liliana; Marshak-Rothstein, Ann (2010) Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 43:76-83
Avalos, Ana M; Uccellini, Melissa B; Lenert, Petar et al. (2010) Fc?RIIB regulation of BCR/TLR-dependent autoreactive B-cell responses. Eur J Immunol 40:2692-8
Richez, Christophe; Yasuda, Kei; Bonegio, Ramon G et al. (2010) IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol 184:796-806

Showing the most recent 10 out of 46 publications